Amanda Yassin

Amanda Yassin practices at Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation.

Amanda Yassin's NPI, 1417256363, was assigned on March 17, 2011. Amanda Yassin holds Florida license 9116250.

Amanda Yassin's primary practice is Cleveland Clinic Martin North Hospital, at 200 SE Hospital Ave, Stuart, FL 34994 in Martin County. The practice phone is (772) 287-5200.

Amanda Yassin's primary practice is Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation. The medical group on file is Cleveland Clinic. Dmand AI also links Amanda Yassin to 1 more medical group, named with a free account. Amanda Yassin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Amanda Yassin practices. Vendor and product names are available with a free account.

Physician assistant is Amanda Yassin's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Amanda Yassin is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Amanda Yassin's licenses on file in 2 states: Florida and New York.

Dmand AI lists bladder disease, enlarged prostate, UTI and vaginal infection among the conditions Amanda Yassin treats.

CMS data shows 1,731 Medicare services from Amanda Yassin across 12 procedure codes in 2024, for 762 Medicare patients. Medicare paid $71,845 for them.

CMS counts 762 Medicare patients who saw Amanda Yassin in 2026. The largest group is 75 to 84, with 362 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Amanda Yassin's median patient age at 73, with 30% women.

In 2026, Amanda Yassin wrote 2,022 Medicare Part D claims for 745 patients. 89% of them were for generic drugs. CMS names the drug for 1,916 of them, across 25 drugs with 11 or more claims each, at $188,537 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Amanda Yassin for performance year 2026, reported through an alternative payment model (APM). Amanda Yassin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Amanda Yassin as offering telehealth.

CMS Open Payments shows 3 general payments to Amanda Yassin from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Teleflex LLC paid the most, $25.